What is the urologist’s role in transgender medicine?
“There is a whole range of ways in which urologists are involved in gender-affirming care,” says Geolani Dy, MD.
In this video, Geolani Dy, MD, and Gaines Blasdel discuss what urologists can do to help transgender patients and how this role will evolve over time. Dy is an Assistant Professor of Urology and Plastic and Reconstructive Surgery at Oregon Health & Science University in Portland, Oregon, who specializes in gender-affirming surgery within the OHSU Transgender Health Program. She also led the creation of Transgender and Non-Binary Surgery Allied Research Collective (TRANS-ARC), which focuses on patient-centered outcomes of genital gender-affirming surgery. Blasdel is a transgender man and gender affirming surgery outcomes researcher at NYU Langone Health in New York City, New York. He is also a TRANS-ARC Steering Committee Member.
Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
February 7th 2022To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
How appropriate use criteria for PSMA-PET imaging optimize patient care
February 2nd 2022In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
Dr. Padmanabhan discusses impact of COVID-19
June 11th 2020Urology Times® Editorial Council Member Priya Padmanabhan, MD, MPH, professor of urology at Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, discusses how she has been affected by the coronavirus disease 2019 (COVID-19) pandemic.
